Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Why is Hebei Changshan Biochemical Pharmaceutical Co., Ltd. ?

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 3.59%

Poor long term growth as Net Sales has grown by an annual rate of -15.30% and Operating profit at -188.74% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

With a fall in Net Sales of -10.54%, the company declared Very Negative results in Mar 25

The company has declared negative results for the last 2 consecutive quarters
INTEREST(HY) At CNY 55.46 MM has Grown at 46.24%
OPERATING CASH FLOW(Y) Lowest at CNY 37.77 MM
NET SALES(HY) At CNY 497.19 MM has Grown at -10.98%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 147.01%, its profits have risen by 77.7%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hebei Changshan Biochemical Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

-100.0%

5.45

80.11%

China Shanghai Composite

15.19%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-15.30%

EBIT Growth (5y)

-188.74%

EBIT to Interest (avg)

-0.61

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

1.45

Sales to Capital Employed (avg)

0.30

Tax Ratio

3.23%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

3.59%

ROE (avg)

3.10%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

27.03

EV to EBIT

-253.38

EV to EBITDA

-383.76

EV to Capital Employed

11.41

EV to Sales

46.52

PEG Ratio

Dividend Yield

ROCE (Latest)

-4.50%

ROE (Latest)

-16.53%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -177.05% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 0.59%

PRE-TAX PROFIT(Q)

At CNY 3.44 MM has Grown at 105.35%

NET PROFIT(Q)

At CNY 3.78 MM has Grown at 106.06%

-19What is not working for the Company

INTEREST(HY)

At CNY 55.46 MM has Grown at 46.24%

OPERATING CASH FLOW(Y)

Lowest at CNY 37.77 MM

NET SALES(HY)

At CNY 497.19 MM has Grown at -10.98%

DEBT-EQUITY RATIO (HY)

Highest at 148.28 %

CASH AND EQV(HY)

Lowest at CNY 517.24 MM

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.01%

Here's what is working for Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Pre-Tax Profit

At CNY 3.44 MM has Grown at 105.35%

over average net sales of the previous four periods of CNY -64.27 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 3.78 MM has Grown at 106.06%

over average net sales of the previous four periods of CNY -62.37 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Inventory Turnover Ratio

Highest at 0.59%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -177.05% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Interest

At CNY 55.46 MM has Grown at 46.24%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales

At CNY 497.19 MM has Grown at -10.98%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Debt-Equity Ratio

Highest at 148.28 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Cash Flow

Lowest at CNY 37.77 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Cash and Eqv

Lowest at CNY 517.24 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debtors Turnover Ratio

Lowest at 3.01%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio